Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00019344
NCT00019344
View on ClinicalTrials.gov
Flavopiridol in Treating Patients With Refractory Cancer
PHASE1
Completed
INTERVENTIONAL
Timeline
Start Date
August 31, 1997
Conditions
Lymphoma
Prostate Cancer
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG
alvocidib
Trial Locations (1)
20892
Medicine Branch, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00019344 - Flavopiridol in Treating Patients With Refractory Cancer | Biotech Hunter | Biotech Hunter